← Browse by Condition
Medical Condition
car t cell related encephalopathy syndrome
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT05043571 Phase 1
Recruiting
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
Enrollment
20 pts
Location
Singapore
Sponsor
National University Hospital, ...
NCT05038696 Phase 1
Recruiting
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
Enrollment
40 pts
Location
Singapore
Sponsor
National University Hospital, ...